Apex Biotechnology Corp. | Income Statement
Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,829
1,789
1,847
1,763
1,795
2,044
Cost of Goods Sold (COGS) incl. D&A
1,281
1,285
1,320
1,304
1,400
1,524
Gross Income
549
504
527
459
396
520
SG&A Expense
200
215
227
213
235
293
EBIT
349
289
301
246
161
227
Unusual Expense
-
-
10
168
4
83
Non Operating Income/Expense
102
34
30
21
40
23
Interest Expense
6
8
10
8
9
11
Pretax Income
447
319
311
52
112
161
Income Tax
56
50
50
49
30
68
Equity in Affiliates
21
-
-
-
-
-
Consolidated Net Income
371
269
262
3
82
94
Net Income
371
273
262
3
86
95
Net Income After Extraordinaries
371
273
262
3
86
95
Net Income Available to Common
371
273
262
3
86
95
EPS (Basic)
3.77
2.77
2.66
0.03
0.86
0.95
Basic Shares Outstanding
99
99
99
100
100
100
EPS (Diluted)
3.60
2.66
2.52
0.03
0.85
0.90
Diluted Shares Outstanding
104
105
107
100
108
112
EBITDA
447
404
413
349
271
333
Non-Operating Interest Income
2
3
1
2
4
5
Minority Interest Expense
-
4
-
-
3
1
About Apex Biotechnology
View Profile
